sameAs
TauopathiesMolecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and PhosphorylationCharacteristics of Tau and Its Ligands in PET ImagingTau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective StrategiesTau physiology and pathomechanisms in frontotemporal lobar degenerationGlial contributions to neurodegeneration in tauopathies.Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.Roles of tau protein in health and disease.Tau PET imaging: present and future directions.Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?Tau protein modifications and interactions: their role in function and dysfunction.Review: tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain?Extracellular Tau Oligomers Induce Invasion of Endogenous Tau into the Somatodendritic Compartment and Axonal Transport Dysfunction.What is the evidence that tau pathology spreads through prion-like propagation?Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration.An Overview on the Clinical Development of Tau-Based Therapeutics.Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies.Tau Protein Dysfunction after Brain IschemiaPreparation of stable tau oligomers for cellular and biochemical studiesTranscellular Spreading of Tau in TauopathiesClustering of Tau fibrils impairs the synaptic composition of α3-Na/K-ATPase and AMPA receptorsThe elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlationNarrow equilibrium window for complex coacervation of tau and RNA under cellular conditionsExtracellular Monomeric Tau Is Internalized by AstrocytesPersistent and Progressive Outer Retina Thinning in Frontotemporal DegenerationAssembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cordPathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathwaysTau exhibits unique seeding properties in globular glial tauopathyTau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic ChallengesEffects of Thioflavin T and GSK-3 Inhibition on Lifespan and Motility in a Model of TauopathyThe Link Between Tau and Insulin Signaling: Implications for Alzheimer's Disease and Other TauopathiesNeurodegeneration, Heterochromatin, and Double-Stranded RNAA walk through tau therapeutic strategiesCrosstalk between Oxidative Stress and TauopathyTau13 Antibody Preferentially Immunoprecipitates High Molecular Weight Tau ProteinsHippocampal Gene Expression is Increased in Late-Stage Alzheimer's Disease
P921
Q22252803-31db6b52-499d-516e-d5b9-23b535e5b480Q26748105-9350E428-5B25-459A-864C-30D06140FA0BQ26769952-0FCC61B5-395E-409F-A9DE-9B49674CC11BQ26769957-4B469C95-4B66-408E-BDBF-6B2125F6D630Q28070250-306D966C-8DD0-4981-B588-2EFA14BC8B3BQ32173558-2B21416A-0F92-4688-B189-A9A8AE53F963Q33393896-30EEDD9F-A660-41C4-8740-18A9297F4C3AQ33559303-DE3A44ED-D137-45A5-877A-BAD58D70D189Q34680852-879F0C6B-A314-4DF5-80AA-6BB527715A0FQ36241505-C52276D1-4F85-4F63-ACB8-196FE01011D0Q37684106-0C032624-5E4E-429A-82CB-AC226F2ACED5Q38061419-713E72D9-B3E7-4179-9767-E08B6D2BFD78Q41594823-380EB2DE-0C53-4E1F-85D2-9BE399F9466FQ47163825-B293157F-0AC1-4A51-BBFA-57AEB6FDF3D1Q52315334-D7FDAD7F-2366-4C40-A525-0D7C3AF823E1Q52344625-57FD1730-E78C-4CE4-B8FE-F38E49AF1618Q52594209-B0812540-88A4-441E-8F48-3F247AF9D2D8Q52598834-FA97571E-6D1F-4016-9EBF-EA3CE652535DQ52679169-277025E3-FBDA-4BBE-89D4-28C4CBCDCE9FQ57066685-BEFF65CF-531D-4381-94F4-F8F575A765AEQ57477631-2D8DCCCE-4627-4ACC-B41B-B8F18C1D53FDQ57838382-FEA87188-21D9-4403-AA19-D874245705D5Q61797575-B2CA3D60-3EB4-463A-BBAE-6F889EF77415Q63101708-C7145BF3-8483-4181-88AC-C4B227A1A883Q64065921-3F89E495-6804-4532-BDED-2DA839660A49Q64068912-59ECFDB8-AA48-426A-94D9-FD7491A89391Q64071268-B1830B43-7933-4DDD-9AD1-D70AF3E6AF06Q64074494-81251905-5176-4B5A-B3D2-85F7B5BBB103Q64076236-F91DD459-3F24-47EA-83B8-C1E2F7956F7CQ64078338-4358BC81-1C14-48AE-BAC0-B40676201ED1Q64085399-FBC905A0-A489-41CB-814F-4CD477ACADCFQ64118930-C6BD1D81-665D-4D65-B71E-C25DD244163CQ64236054-353E536F-2B06-4914-A8DE-5FD6CB3F7F6DQ64237552-04547778-E7CC-4C44-B1E0-F17BCC87FF2CQ64237943-B6FABDF3-5D6A-44F9-96A2-1D7147EA9FD4Q64245316-AD7DC1FB-E659-4E8D-844A-5B23CAD19E56Q64245708-CDA3428F-3A6B-414D-9D6F-5E0A31B45FC5Q64249418-0013C6B0-F4A6-429D-8CAF-410F88935DE4Q64255829-9CABDBC3-9EF0-46DA-B4A9-8958B34E5908Q64259971-54679629-DEAC-4501-B27E-98A101B78CB6
P921
description
Nervenkrankheit
@de
neurodegenerative disease caused by tau protein aggregates
@en
nevrodegenerativ sjukdom som skuldast opphoping av tauprotein
@nn
patologie neurodegenerative pr ...... metabolismo della Proteina tau
@it
нэўрадэгенэратыўнае захворваньне
@be-tarask
name
Tauopathie
@de
Tauopathie
@nl
Tauopati
@da
Tauopatie
@pl
Tau蛋白質異常沉積
@zh
tauopathie
@fr
tauopathy
@en
tauopati
@nn
tauopatija
@hr
taupatia
@ca
type
label
Tauopathie
@de
Tauopathie
@nl
Tauopati
@da
Tauopatie
@pl
Tau蛋白質異常沉積
@zh
tauopathie
@fr
tauopathy
@en
tauopati
@nn
tauopatija
@hr
taupatia
@ca
altLabel
Tauopatia
@pl
Tau蛋白病
@zh
tauopathies
@en
prefLabel
Tauopathie
@de
Tauopathie
@nl
Tauopati
@da
Tauopatie
@pl
Tau蛋白質異常沉積
@zh
tauopathie
@fr
tauopathy
@en
tauopati
@nn
tauopatija
@hr
taupatia
@ca
P486
P6366
P646
P672
P18
P1995
P2892
P31
P373
Tauopathies
P3827
tauopathies
P486
P5270
MONDO:0005574
P6366
2777739294
P646
P672
C10.574.945